1 / 2

Global Outlook on The Automated Breast Ultrasound System (ABUS) Market Industry: Size & Share, Trend and Growth | Foreca

Global automated breast ultrasound systems market size is forecast to grow by USD 422.74 million during 2019-2023 at a CAGR of 14%, with hospitals and clinics segment having the largest market share. ABUS market analysis indicates growth will be driven by the increasing demand for breast imaging products owing to the increasing prevalence of breast cancer cases. ABUS industry growth will also be impacted by the expanding focus on the development of integrated and innovative automated breast ultr

sarahbennu
Download Presentation

Global Outlook on The Automated Breast Ultrasound System (ABUS) Market Industry: Size & Share, Trend and Growth | Foreca

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Outlook on The Automated Breast Ultrasound System (ABUS) Market Industry: Size & Share, Trend and Growth | Forecast Analysis 2019 – 2023 Technavio has announced its latest market research report titled global automated breast ultrasound systems (ABUS) market 2019-2023. ABUS market analysis indicates growth will be driven by the increasing demand for breast imaging products owing to the increasing prevalence of breast cancer cases. ABUS industry growth will also be impacted by the expanding focus on the development of integrated and innovative automated breast ultra The rise in breast cancer cases across the world, especially in the Americas and Europe, have increased the need to conduct breast cancer screening. This has increased the demand for breast imaging products such as automated breast ultrasound systems for early screening and diagnosis. Thus, the high demand for breast imaging products will fuel the growth of the ABUS market. Furthermore, this industry research report also presents a competitive analysis of the market by end-users (hospitals & clinics, and diagnostic centres) and geography (North America, Europe, ROW, and Asia). Competitive vendor landscape The global automated breast ultrasound systems (ABUS) market is highly competitive with major vendors such as GE Healthcare; Hitachi, Ltd.; Koninklijke Philips N.V.; Siemens Healthineers AG; and SonoCiné competing on the basis of price, quality, and market presence. “The market is witnessing increased focus on the development of integrated and innovative automated breast ultrasound systems. These integrated and innovative systems help clinicians understand the medical conditions of a patient with greater precision. Such innovations will fuel the growth of the ABUS market size during the forecast period,” says a senior analyst at Technavio.

  2. Top five automated breast ultrasound systems (ABUS) market vendors GE Healthcare GE Healthcare is one of the most popular companies in the global healthcare landscape, which operates under two business segments, namely healthcare systems and life sciences. The company offers Invenia ABUS 2.0, which uses 3D ultrasound technology to image women with dense breast tissue. Hitachi, Ltd. Hitachi, Ltd. is a leading manufacturer of information & telecommunication systems, social infrastructure & industrial systems, electronic systems & equipment, construction machinery, high functional materials & components, automotive systems, and smart life & eco-friendly systems. The company’s key offering in this market includes SOFIA, which provides a fully automated scan procedure with whole breast image acquisition. Koninklijke Koninklijke owns and operates various businesses including personal health, diagnosis & treatment, connected care & health informatics, and others. The company offers Philips EPIQ and Affiniti ultrasound systems, which come equipped with an integrated eL18-4 transducer and anatomical intelligence for proper imaging of the breast with high tissue density. Siemens Healthineers AG Siemens Healthineers AG operates under three segments, namely imaging, diagnostics, and advanced therapies. The key offering of the company in the ABUS market include ACUSON S2000 ABVS, which provides a 3D total breast ultrasound to identify lesions or other areas of concern in fatty and dense breast tissue. SonoCiné SonoCiné offers technology products which are used for vascular, orthopedic ultrasound, breast, echocardiography, MRI, and CT scan applications. The company offers SonoCiné AWBUS, which provides consistent, repeatable scan of the whole breast, including the axilla, for proper detection of cancer. Looking for more information on this market? Request a free sample report Browse Related Reports: Global Digital Breast Tomosynthesis Market 2019-2023 - The market research study identifies FUJIFILM, GE Healthcare, GMM (IMS GIOTTO), Hologic, PLANMECA (PLANMED), and Siemens Healthineers, as the leading players in the global digital breast tomosynthesis market. Global Breast Cancer Therapeutics Market 2019-2023 - The market research study identifies AstraZeneca, Eli Lilly, F. Hoffmann-La Roche, Novartis, and Pfizer, as the leading players in the global breast cancer therapeutics market. • •

More Related